Rumi Viro

Rumi Viro’s mission is to mitigate the impact viruses have on human health, via its human stem cell technology that uses state-of-the-art imaging and analytical tools to inexpensively and effectively identify antiviral treatments for human infectious diseases.
For inquiries, please contact us at
E-mail: info@rumiviro.science
 

Ilona Nemeth

Ilona Nemeth, MBA., CEO

 

Ms. Nemeth has been an executive in high-growth businesses as well as managing an investment portfolio. Prior to overseeing several business areas within DoubleClick, (an original Internet ad – serving technology company, now owned by Google), she headed high-tech materials Strategy & Acquisitions for AlliedSignal (now Honeywell) and worked before that at Goldman Sachs. Ilona received an MBA from INSEAD in France, and graduated Phi Beta Kappa from Columbia University. She has served on several councils and advisory boards, including technology-provider Catchpoint, at Rockefeller University, the INSEAD Alumni Fund and the American Advisory Board of the London Symphony Orchestra.


I would like to learn about Rumi Viro’s novel discoveries to treat genetic diseases.